Clinical Trial Update: a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Agnucaston Tablets for the treatment of Premenstrual Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Syndrome

Drugs mentioned

• Agnucaston Tablets (Vitex agnus-castus extract)

Snippet

Sponsor: Schwabe-Wenex International Ltd | Conditions: Premenstrual Syndrome | Phase 2 | Status: COMPLETED